|
1
|
Tao Q and Chan AT: Nasopharyngeal
carcinoma: molecular pathogenesis and therapeutic developments.
Expert Rev Mol Med. 9:1–24. 2007.PubMed/NCBI
|
|
2
|
Kawasaki BT, Hurt EM, Mistree T and Farrar
WL: Targeting cancer stem cells with phytochemicals. Mol Interv.
8:174–184. 2008. View
Article : Google Scholar
|
|
3
|
Keysar SB and Jimeno A: More than markers:
biological significance of cancer stem cell-defining molecules. Mol
Cancer Ther. 9:2450–2457. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Patrawala L, Calhoun T,
Schneider-Broussard R, Zhou J, Claypool K and Tang DG: Side
population is enriched in tumorigenic, stem-like cancer cells,
whereas ABCG2+ and ABCG2− cancer cells are
similarly tumorigenic. Cancer Res. 65:6207–6219. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ho MM, Ng AV, Lam S and Hung JY: Side
population in human lung cancer cell lines and tumors is enriched
with stem-like cancer cells. Cancer Res. 67:4827–4833. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang J, Wei X, Ling J, Huang Y, Huo Y and
Zhou Y: The presence of a side population and its marker ABCG2 in
human deciduous dental pulp cells. Biochem Biophys Res Commun.
400:334–339. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Alison MR, Lim SM and Nicholson LJ: Cancer
stem cells: problems for therapy. J Pathol. 223:147–161. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pannuti A, Foreman K, Rizzo P, et al:
Targeting Notch to target cancer stem cells. Clin Cancer Res.
16:3141–3152. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang M, Li JT, Zeng YX, Hou JH and Lin QQ:
Expression and significance of Notch1, p21WAF1 and involucrin in
nasopharyngeal carcinoma. Ai Zheng. 24:1230–1234. 2005.(In
Chinese).
|
|
10
|
Zhang Y, Peng J, Zhang H, et al: Notch1
signaling is activated in cells expressing embryonic stem cell
proteins in human primary nasopharyngeal carcinoma. J Otolaryngol
Head Neck Surg. 39:157–166. 2010.PubMed/NCBI
|
|
11
|
Yu S, Zhang R, Liu F, Hu H, Yu S and Wang
H: Down-regulation of Notch signaling by a γ-secretase inhibitor
enhances the radiosensitivity of nasopharyngeal carcinoma cells.
Oncol Rep. 26:1323–1328. 2011.
|
|
12
|
Bao S, Wu Q, McLendon RE, et al: Glioma
stem cells promote radioresistance by preferential activation of
the DNA damage response. Nature. 756–760. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Phillips TM, McBride WH and Pajonk F: The
response of CD24(-/low)/CD44+ breast cancer-initiating
cells to radiation. J Natl Cancer Inst. 98:1777–1785.
2006.PubMed/NCBI
|
|
14
|
Woodward WA, Chen MS, Behbod F, Alfaro MP,
Buchholz TA and Rosen JM: WNT/beta-catenin mediates radiation
resistance of mouse mammary progenitor cells. Proc Natl Acad Sci
USA. 104:618–623. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yu S, Zhang R, Liu F, Hu H, Yu S and Wang
H: Down-regulation of Notch signaling by a γ-secretase inhibitor
enhances the radiosensitivity of nasopharyngeal carcinoma cells.
Oncol Rep. 26:1323–1328. 2011.
|
|
16
|
Wang J, Guo LP, Chen LZ, Zeng YX and Lu
SH: Identification of cancer stem cell-like side population cells
in human nasopharyngeal carcinoma cell line. Cancer Res.
67:3716–3724. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shi GM, Xu Y, Fan J, et al: Identification
of side population cells in human hepatocellular carcinoma cell
lines with stepwise metastatic potentials. J Cancer Res Clin Oncol.
134:1155–1163. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang Q, Li Y and Lin X: A survival
analysis of nasopharyngeal carcinoma from 1995 to 2004 in Sihui,
Guangdong. Bull Chin Cancer. 3:150–151. 2007.
|
|
19
|
Artavanis-Tsakonas S, Rand MD and Lake RJ:
Notch signaling: cell fate control and signal integration in
development. Science. 284:770–776. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lino MM, Merlo A and Boulay JL: Notch
signaling in glioblastoma: a developmental drug target. BMC Med.
8:722010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lai EC: Notch signaling: control of cell
communication and cell fate. Development. 131:965–973. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fukaya R, Ohta S, Yamaguchi M, et al:
Isolation of cancer stem-like cells from a side population of a
human glioblastoma cell line, SK-MG-1. Cancer Lett. 291:150–157.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Guo S, Liu M and Gonzalez-Perez RR: Role
of Notch and its oncogenic signaling crosstalk in breast cancer.
Biochim Biophys Acta. 1815:197–213. 2011.PubMed/NCBI
|
|
24
|
Zhang Y, Li B, Ji ZZ and Zheng PS: Notch1
regulates the growth of human colon cancers. Cancer. 116:5207–5218.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Harrison H, Farnie G, Howell SJ, et al:
Regulation of breast cancer stem cell activity by signaling through
the Notch4 receptor. Cancer Res. 70:709–718. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yung WK: Tumor stem cells, notch, and the
news. Neuro Oncol. 12:1152010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hu YY, Zheng MH, Cheng G, et al: Notch
signaling contributes to the maintenance of both normal neural stem
cells and patient-derived glioma stem cells. BMC Cancer. 11:822011.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang XP, Zheng G, Zou L, et al: Notch
activation promotes cell proliferation and the formation of neural
stem cell-like colonies in human glioma cells. Mol Cell Biochem.
307:101–108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fan X, Khaki L, Zhu TS, et al: NOTCH
pathway blockade depletes CD133-positive glioblastoma cells and
inhibits growth of tumor neurospheres and xenografts. Stem Cells.
28:5–16. 2010.PubMed/NCBI
|
|
30
|
Sikandar SS, Pate KT, Anderson S, et al:
NOTCH signaling is required for formation and self-renewal of
tumor-initiating cells and for repression of secretory cell
differentiation in colon cancer. Cancer Res. 70:1469–1478. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhen Y, Zhao S, Li Q, Li Y and Kawamoto K:
Arsenic trioxide-mediated Notch pathway inhibition depletes the
cancer stem-like cell population in gliomas. Cancer Lett.
292:64–72. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Nam Y, Aster JC and Blacklow SC: Notch
signaling as a therapeutic target. Curr Opin Chem Biol. 6:501–509.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tien AC, Rajan A and Bellen HJ: A Notch
updated. J Cell Biol. 184:621–629. 2009. View Article : Google Scholar
|
|
34
|
Kopan R and Ilagan MX: Gamma-secretase:
proteasome of the membrane. Nat Rev Mol Cell Biol. 5:499–504. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Suwanjunee S, Wongchana W and Palaga T:
Inhibition of gamma-secretase affects proliferation of leukemia and
hepatoma cell lines through Notch signaling. Anticancer Drugs.
19:477–486. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Vermeulen L, Sprick MR, Kemper K, Stassi G
and Medema JP: Cancer stem cells - old concepts, new insights. Cell
Death Differ. 947–958. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chikazawa N, Tanaka H, Tasaka T, et al:
Inhibition of Wnt signaling pathway decreases
chemotherapy-resistant side-population colon cancer cells.
Anticancer Res. 30:2041–2048. 2010.PubMed/NCBI
|
